MEMORY ENHANCEMENT DRUGS MARKET ANALYSIS

Memory Enhancement Drugs Market, By Drug Class (Cholinesterase Inhibitors, Smart Drugs and Cognitive Enhancers (Nootropics) and Vitamins and Supplements and others), by Route of Administration (Oral, Topical, Injectable), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy ,Online Pharmacy, Drug Stores), by Application (Disease treatment, Athletic performance, Academic performance and others), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Dec 2022
Code : CMI5399
Pages :156
Formats :
Excel and PDF
Industry : Pharmaceutical

Memory Enhancement Drugs MarketSize and Trends

Global memory enhancement drugs market is estimated to be valued at US$ 7,912.1 million in 2022 and is expected to exhibit a CAGR of 5.5% during the forecast period (2022-2030).

Figure 1. Global Memory Enhancement Drugs Market Share (%) in Terms of Value, By Route of Administration

Global Memory Enhancement Drugs Market- Drivers

Increasing prevalence of aging population is expected to drive the global memory enhancement drugs market growth over the forecast period. For instance, According to an article published on March 2021, on Alzheimer’s Association, estimated that 6.2 million Americans age 65 and older are living with Alzheimer's dementia.

Increasing prevalence of neurological disorders are expected to drive the market growth during the forecast period. For instance, according to Neurological Alliance Report published on March 2019, there are an estimated 14.7 million neurological cases, equating to at least 1 in 6 people living with one or more neurological conditions.